VOLITIONRX LTD 8-K

What Happened

• On May 14, 2026 VolitionRx Limited issued a press release announcing its financial results and business updates for the quarter ended March 31, 2026. The company confirmed an investor conference call for May 15, 2026 at 8:30 a.m. U.S. Eastern Time. The press release was furnished as Exhibit 99.1 to the Form 8-K.

Key Details

• Press release dated May 14, 2026 covering quarterly results for the period ended March 31, 2026 (Exhibit 99.1 furnished).
• Company confirmed a conference call on May 15, 2026 at 8:30 a.m. ET to discuss results and updates.
• The information was furnished under Item 2.02 (Results of Operations and Financial Condition) and included as an exhibit under Item 9.01; the filing notes the press release is “furnished” (not “filed”) under SEC rules.

Why It Matters

• This filing notifies investors that VolitionRx has released its latest quarterly results and will hold a call to discuss performance and business developments; investors should review the press release for details on earnings, revenue, and other financial metrics. Because the release was furnished rather than filed, it is not subject to the broader liabilities of Section 18 and is not automatically incorporated by reference into other SEC filings.